FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Global Pharma Healthcare Private Delsam Pharma's ARTIFICIAL TEARS Recall

Delsam Pharma's ARTIFICIAL TEARS (Carboxymethylcellulose Sodium) Lubricant Eye Drops, 1…

Global Pharma Healthcare Private Limited · Chennai, N/A

Risk level
Class II
Reported by FDA
Jul 19, 2023
Recall ID
D-0922-2023
Check your lot numberHow we source this data

Summary

Global Pharma Healthcare Private recalled Delsam Pharma's ARTIFICIAL TEARS starting Jan 30, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0922-2023 on Jul 19, 2023. Reason: CGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manufactured in the same facility under the same conditions as the lots found to be contaminated. Status: Ongoing.

Why it was recalled

CGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manufactured in the same facility under the same conditions as the lots found to be contaminated.

Product description

Delsam Pharma's ARTIFICIAL TEARS (Carboxymethylcellulose Sodium) Lubricant Eye Drops, 10 MG in 1 ml, 1%, 1/2 fl oz (15 ml) bottle, Distributed By: Delsam Pharma Llc, Bronx, New York 10467, NDC 72570 121 15.

Lot numbers, UPCs & expiration codes

Lot #: PCMH003, PCMH004, PCMH006, PCMH008, Exp. date NOV-2023

Where it was sold

Product was distributed to two distributors who further distributed Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0922-2023
Classification
Class II
Status
Ongoing
Recall initiated
Jan 30, 2023
FDA report date
Jul 19, 2023
Quantity
400,008 bottles total for all products
Recall type
Voluntary: Firm initiated
Recalling firm
Global Pharma Healthcare Private Limited

Original FDA data

Every field from FDA enforcement report D-0922-2023, exactly as published.

Show all FDA fields
City
Chennai
Status
Ongoing
Country
India
Event ID
91621
Address
A - 9 Sidco Pharmaceutical Complex
Address (line 2)
Thiruporur
Code information
Lot #: PCMH003, PCMH004, PCMH006, PCMH008, Exp. date NOV-2023
Report date
Jul 19, 2023
Product type
Drugs
Recall number
D-0922-2023
Classification
Class II
Recalling firm
Global Pharma Healthcare Private Limited
Product quantity
400,008 bottles total for all products
Reason for recall
CGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manufactured in the same facility under the same conditions as the lots found to be contaminated.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Delsam Pharma's ARTIFICIAL TEARS (Carboxymethylcellulose Sodium) Lubricant Eye Drops, 10 MG in 1 ml, 1%, 1/2 fl oz (15 ml) bottle, Distributed By: Delsam Pharma Llc, Bronx, New York 10467, NDC 72570 121 15.
Distribution pattern
Product was distributed to two distributors who further distributed Nationwide in the USA.
Recall initiation date
Jan 30, 2023
Initial firm notification
E-Mail
Center classification date
Jul 14, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0922-2023, published Jul 19, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls